4d Molecular Therapeutics In shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $269k | 31k | 8.69 |
| 2025-06-30 | $96k | 26k | 3.71 |
| 2025-03-31 | $76k | 24k | 3.23 |
| 2024-12-31 | $144k | 26k | 5.57 |
| 2024-09-30 | $199k | 18k | 10.81 |
| 2024-06-30 | $383k | 18k | 20.99 |
| 2024-03-31 | $457k | 14k | 31.86 |
| 2023-12-31 | $249k | 12k | 20.26 |
| 2023-09-30 | $409k | 32k | 12.73 |
| 2023-06-30 | $706k | 39k | 18.07 |
| 2022-12-31 | $4.4k | 200 | 22.21 |
| 2022-09-30 | $3.9k | 269 | 14.49 |
| 2022-06-30 | $2.7k | 548 | 5.00 |
| 2022-03-31 | $168k | 11k | 15.16 |
| 2021-12-31 | $444k | 20k | 21.96 |
| 2021-09-30 | $206k | 7.7k | 26.85 |
| 2021-06-30 | $21k | 825 | 25.36 |
| 2021-03-31 | $106k | 2.4k | 43.44 |